BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 31763299)

  • 1. Ossifying Fibroma of Maxilla in a Female Affected by Neurofibromatosis Type 1.
    Jendi SK; Khatib S; Mistry J; Wagh A; Vaidya K; Kokane G
    Indian J Otolaryngol Head Neck Surg; 2019 Nov; 71(Suppl 3):2087-2090. PubMed ID: 31763299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jaffe-Campanacci syndrome or neurofibromatosis type 1: a case report of phenotypic overlap with detection of NF1 gene mutation in non-ossifying fibroma.
    Vannelli S; Buganza R; Runfola F; Mussinatto I; Andreacchio A; de Sanctis L
    Ital J Pediatr; 2020 May; 46(1):58. PubMed ID: 32393377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Café-au-lait Macules and Neurofibromatosis Type 1: A Review of the Literature.
    Bernier A; Larbrisseau A; Perreault S
    Pediatr Neurol; 2016 Jul; 60():24-29.e1. PubMed ID: 27212418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofibromatosis type 1.
    Anderson JL; Gutmann DH
    Handb Clin Neurol; 2015; 132():75-86. PubMed ID: 26564071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
    Sabol Z; Kipke-Sabol L
    Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
    Hernández-Martín A; Duat-Rodríguez A
    Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurofibromatosis type 1 or Von Recklinghausen's disease].
    Pinson S; Wolkenstein P
    Rev Med Interne; 2005 Mar; 26(3):196-215. PubMed ID: 15777582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment With Selumetinib for Café-au-Lait Macules and Plexiform Neurofibroma in Pediatric Patients With Neurofibromatosis Type 1.
    Guo YX; Wang HX; Wang SS; Croitoru D; Piguet V; Gao XH; Xu XG
    JAMA Dermatol; 2024 Mar; 160(3):366-368. PubMed ID: 38198164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mandibular neurofibroma with osseous deformities in a 3-year-old child with neurofibromatosis type 1: A case report presentation and diagnosis.
    Aloyouny AY; Albagieh HN; Alweteid AS; Alsheddi MA
    Niger J Clin Pract; 2021 Nov; 24(11):1755-1757. PubMed ID: 34782519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease.
    Hernández-Martín A; Duat-Rodríguez A
    Actas Dermosifiliogr; 2016; 107(6):454-64. PubMed ID: 26979265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of neurofibromatosis 1 (NF1) lesions by body segment.
    Palmer C; Szudek J; Joe H; Riccardi VM; Friedman JM
    Am J Med Genet A; 2004 Mar; 125A(2):157-61. PubMed ID: 14981716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically confirmed coexistence of neurofibromatosis type 1 and Cherubism in a pediatric patient.
    Sarantou S; Marinakis NM; Traeger-Synodinos J; Siomou E; Ntinopoulos A; Serbis A
    Mol Biol Rep; 2024 Jan; 51(1):216. PubMed ID: 38281202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
    Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
    Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report for Two Siblings Carrying Neurofibromatosis Type 1 with a Rare
    Sayın Kocakap DB; Gündüz Ö; Özer L; Durak M
    Balkan J Med Genet; 2021 Nov; 24(2):99-102. PubMed ID: 36249525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous Findings in Neurofibromatosis Type 1.
    Ozarslan B; Russo T; Argenziano G; Santoro C; Piccolo V
    Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33530415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Musculoskeletal manifestations of neurofibromatosis type 1 (von Recklinghausen's disease) and tuberous sclerosis (Bourneville's disease)].
    Uhl M
    Radiologe; 2021 Dec; 61(12):1090-1095. PubMed ID: 34309712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurofibromatosis from Head to Toe: What the Radiologist Needs to Know.
    Wang MX; Dillman JR; Guccione J; Habiba A; Maher M; Kamel S; Panse PM; Jensen CT; Elsayes KM
    Radiographics; 2022; 42(4):1123-1144. PubMed ID: 35749292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Neurofibromas in Type I Neurofibromatosis. Description of a clinical case and literature review].
    Del Puerto C; Aspee M; Downey C
    Andes Pediatr; 2022 Oct; 93(5):741-748. PubMed ID: 37906895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Manifestations in Von Recklinghausen's Disease: A Rare Presentation.
    Leggett LR; Alexis F; Agarwal N; Bakhtin Z; Farabi B
    Cureus; 2022 Mar; 14(3):e23365. PubMed ID: 35475080
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.